These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 132848)

  • 1. Generation of kinin by plasma kallikrein and plasmin and the effect of alpha1-antitrypsin and antithrombin III on the kinongenases.
    Habal FM; Burrowes CE; Movat HZ
    Adv Exp Med Biol; 1976; 70(00):23-36. PubMed ID: 132848
    [No Abstract]   [Full Text] [Related]  

  • 2. Activation of human Glu-plasminogen to Glu-plasmin by urokinase in presence of plasmin inhibitors. Streptomyces leupeptin and human plasma alpha1-antitrypsin and antithrombin III (plus heparin).
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    J Biol Chem; 1977 Jun; 252(11):3945-51. PubMed ID: 140876
    [No Abstract]   [Full Text] [Related]  

  • 3. Interaction of leukocytes and endotoxin with the plasmin and kinin systems.
    Miller RL; Webster ME; Melmon KL
    Eur J Pharmacol; 1975 Aug; 33(1):53-60. PubMed ID: 126170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Hageman factor dependent pathways of coagulation, fibrinolysis, and kinin-generation.
    Kaplan AP; Meier HL; Mandle R
    Semin Thromb Hemost; 1976 Jul; 3(1):1-26. PubMed ID: 139682
    [No Abstract]   [Full Text] [Related]  

  • 5. Alpha 1-antitrypsin and alpha 2-macroglobulin do not inhibit the kinin-releasing activity of kallikreins from human urine and saliva.
    Sakamoto W; Nishikaze O
    Biochim Biophys Acta; 1980 Dec; 633(3):305-9. PubMed ID: 6163451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of enhanced kinin release from high molecular weight kininogen by plasma kallikrein after its exposure to plasmin.
    Kleniewski J; Blankenship DT; Cardin AD; Donaldson V
    J Lab Clin Med; 1992 Jul; 120(1):129-39. PubMed ID: 1535355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mouse plasma trypsin inhibitors: inhibitory spectrum of contrapsin and alpha-1-antitrypsin.
    Takahara H; Sinohara H
    Thromb Res; 1982 Jul; 27(1):45-50. PubMed ID: 6214866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antithrombin activity of alpha-1-protease inhibitor: the antitrypsin activity of antithrombin III.
    Learned LA; Bloom JW; Hunter MJ
    Thromb Res; 1976 Jan; 8(1):99-109. PubMed ID: 1082656
    [No Abstract]   [Full Text] [Related]  

  • 10. Actions of urinary kallikrein, plasmin, and other kininogenases on bovine plasma high-molecular-weight kininogen.
    Han YN; Kato H; Iwanaga S; Komiya M
    J Biochem; 1978 Jan; 83(1):223-35. PubMed ID: 146707
    [No Abstract]   [Full Text] [Related]  

  • 11. Kallikreins, kininogens and kinin receptors on circulating and synovial fluid neutrophils: role in kinin generation in rheumatoid arthritis.
    Cassim B; Shaw OM; Mazur M; Misso NL; Naran A; Langlands DR; Thompson PJ; Bhoola KD
    Rheumatology (Oxford); 2009 May; 48(5):490-6. PubMed ID: 19254919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivity of alpha 1-antitrypsin mutants against proteolytic enzymes of the kallikrein-kinin, complement, and fibrinolytic systems.
    Patston PA; Roodi N; Schifferli JA; Bischoff R; Courtney M; Schapira M
    J Biol Chem; 1990 Jun; 265(18):10786-91. PubMed ID: 2191958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biochemistry of the kallikrein-kinin system].
    Kato H; Fujii S
    Nihon Rinsho; 1978 Aug; 36(8):2865-72. PubMed ID: 152362
    [No Abstract]   [Full Text] [Related]  

  • 14. The kinin system: its relation to blood coagulation, fibrinolysis and the formed elements of the blood.
    Movat HZ
    Rev Physiol Biochem Pharmacol; 1978; 84():143-202. PubMed ID: 152965
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterization of human salivary kallikrein: reactivities to human plasma kininogens and proteinase inhibitors.
    Sakamoto W; Yoshikawa K; Uehara S; Nishikaze O
    J Biochem; 1983 Mar; 93(3):833-8. PubMed ID: 6553577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of plasmin on the kinin system of rat blood].
    Andreenko GV; Suvorov AV
    Nauchnye Doki Vyss Shkoly Biol Nauki; 1975; (4):44-8. PubMed ID: 130169
    [No Abstract]   [Full Text] [Related]  

  • 17. [The kinin and plasmin systems of the blood serum and cerebro- spinal fluid in patients with multiple sclerosis and schizophrenia].
    Vilkov GA; Martirosian VV; Trapezontseva RA; Kozlova LS; Ellanskiĭ IuIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(7):23-7. PubMed ID: 2477972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The inhibitory effect of plasma inhibitor on plasmin activated with streptokinase or urokinase.
    Sumi H; Takada Y; Takada A
    Nihon Seirigaku Zasshi; 1977; 39(5):112-4. PubMed ID: 72149
    [No Abstract]   [Full Text] [Related]  

  • 19. Expression and characterization of human tissue kallikrein variants.
    Chan H; Springman EB; Clark JM
    Protein Expr Purif; 1998 Apr; 12(3):361-70. PubMed ID: 9535704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kallikrein-kinin system as mediator in vasogenic brain edema. Part 2: Studies on kinin formation in focal and perifocal brain tissue.
    Maier-Hauff K; Baethmann AJ; Lange M; Schürer L; Unterberg A
    J Neurosurg; 1984 Jul; 61(1):97-106. PubMed ID: 6563063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.